Dexmeditomedine for mitral valve replacement

Phase 3

Recruiting

• Conditions: patients with tight mitral stenosis scheduled for mitral valve replacement; Anaesthesiology - Anaesthetics; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12613000495729
• Lead Sponsor: south valley university -Qena university hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-05-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

patients ASAI&II with tight ( less than one centimeter ) mitral stenosis aged 18-60 years of age scheduled for mitral valve replacement

Exclusion Criteria

age above or below 18-60 years , mitral valve area more than one centimeter, renal or hepatic dysfunction , cardiac medications that affect heart rate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
heart rate changes as measured by pulse oximeter and ECG[the start of infusion following a bolus of dexmeditomedine after induction of anesthesia and every 10 minutes after the end of the bolus till the start of cardiopulmonary bypass]

Secondary Outcome Measures

Name	Time	Method
nil[none]